You are here:

mesalazine (Asacol)


Following an abbreviated submission

Mesalazine 800 mg modified release tablet (Asacol) is accepted for use in NHS Scotland for the treatment of mild acute exacerbations of ulcerative colitis.

At the recommended dose of up to 2.4g daily, the 800 mg strength allows halving of the pill burden compared with the 400 mg formulation at no extra cost.

Drug Details

Drug Name: mesalazine (Asacol)
SMC Drug ID: 223/05
Manufacturer: Procter and Gamble
Indication: Mild acute exacerbations for ulcerative colitis
BNF Category:
Sub Category: 1.5 Chronic bowel disorders
Submission Type: Abbreviated Submission
Status: Accepted
Date Advice Published: 11 February 2008